These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12452522)

  • 1. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus.
    Dremencov E; Gur E; Lerer B; Newman ME
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1029-34. PubMed ID: 12452522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus.
    Dremencov E; Gur E; Lerer B; Newman ME
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):729-39. PubMed ID: 12921903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
    Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
    Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha and interleukin-2 differentially affect hippocampal serotonergic neurotransmission, behavioural activity, body temperature and hypothalamic-pituitary-adrenocortical axis activity in the rat.
    Pauli S; Linthorst AC; Reul JM
    Eur J Neurosci; 1998 Mar; 10(3):868-78. PubMed ID: 9753154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of antidepressants].
    Llorca PM; Reine G; Wolf MA
    Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies.
    de Montigny C; Blier P
    Adv Biochem Psychopharmacol; 1984; 39():223-39. PubMed ID: 6087626
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of the 5-HT neurotransmission by antidepressant treatments.
    De Montigny C
    J Physiol (Paris); 1981; 77(2-3):455-61. PubMed ID: 6270317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological factors and resistance to antidepressive agents].
    Puech AJ; Corruble E
    Encephale; 1995 Mar; 21 Spec No 2():17-21. PubMed ID: 7588173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
    Gur E; Lifschytz T; Van De Kar LD; Lerer B; Newman ME
    Psychoneuroendocrinology; 2004 Oct; 29(9):1172-83. PubMed ID: 15219641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex.
    Okamoto Y; Motohasi N; Hayakawa H; Muraoka M; Yamawaki S
    Neuropsychobiology; 1996; 33(1):17-20. PubMed ID: 8821370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ
    Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors.
    Zhu H; Huang Q; Xu H; Niu L; Zhou JN
    Behav Brain Res; 2009 Jan; 196(2):200-6. PubMed ID: 18817816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity.
    Szabo ST; Blier P
    Biol Psychiatry; 2001 Oct; 50(8):644-6. PubMed ID: 11690604
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.
    Bauer M; Adli M; Baethge C; Berghöfer A; Sasse J; Heinz A; Bschor T
    Can J Psychiatry; 2003 Aug; 48(7):440-8. PubMed ID: 12971013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of serotonin neurotransmission by antidepressant drugs and electroconvulsive shock: the fall and rise of serotonin receptors.
    Kellar KJ; Stockmeier CA; Gomez JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():138-45. PubMed ID: 2984881
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention.
    Kurhe Y; Mahesh R
    Asian J Psychiatr; 2015 Oct; 17():3-9. PubMed ID: 26243683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
    Mongeau R; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1152-9. PubMed ID: 7912278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.